Healthy Skepticism Library
Items published in 2010
There are 1617 items in the Healthy Skepticism Library that were published in 2010.
Page 16 of 17 pages ‹ First < 14 15 16 17 >
HSL17032
Taylor L
US govt study probes “extraordinary” Rx price rises
Pharma Times 2010 Jan 12
http://www.pharmatimes.com/WorldNews/article.aspx?id=17194
HSL17042
Hopkins Tanne J
Harvard tightens rules on industry payments to top professors
BMJ 2010 Jan 12;
http://www.bmj.com/cgi/content/extract/340/jan12_2/c172
HSL17048
Watson R
Politician accuses drug companies of overplaying dangers of H1N1
BMJ 2010 Jan 12;
http://www.bmj.com/cgi/content/extract/340/jan12_2/c198
HSL17099
Ferring and Stiefel named and shamed for Code breaches
InPharm 2010 Jan 12
http://www.inpharm.com/news/ferring-and-stiefel-named-and-shamed-code-breaches
HSL17188
Strong C
Why Academic Medical Centers Should Ban Drug Company Gifts to Individuals
The American Journal of Bioethics 2010 Jan 12; 10:(1):13-15
http://www.informaworld.com/smpp/content~content=a918536913~db=all
HSL17189
Morreim H
The Devil in the Detail(ing)
The American Journal of Bioethics 2010 Jan 12; 10:(1):15-17
http://www.informaworld.com/smpp/content~content=a918535960~db=all
HSL17191
Schwab AP
The Details Are in the Field
The American Journal of Bioethics 2010 Jan 12; 10:(1):19-21
http://www.informaworld.com/smpp/content~content=a918540981~db=all
HSL17192
Steinman MA, Schillinger D
Drug Detailing in Academic Medical Centers: Regulating for the Right Reasons, with the Right Evidence, at the Right Time
The American Journal of Bioethics 2010 Jan 12; 10:(1):21-23
http://www.informaworld.com/smpp/content~content=a918537171~db=all
HSL17193
Spielman B
The Pitfalls of Misreading: What Does 'Industry Funding of Medical Education' Actually Say?
The American Journal of Bioethics 2010 Jan 12; 10:(1):24-25
http://www.informaworld.com/smpp/content~content=a918541102~db=all
HSL17194
Stossel TP
The AAMC Exhibits the Behavior it Condemns
The American Journal of Bioethics 2010 Jan 12; 10:(1):26-27
http://www.informaworld.com/smpp/content~content=a918536404~db=all
HSL17195
Stell LK
Avoiding Over-Deterrence in Managing Physicians' Relationships With Industry
The American Journal of Bioethics 2010 Jan 12; 10:(1):27-29
http://www.informaworld.com/smpp/content~content=a918538358~db=all
HSL17028
Wilson D
Using a Pfizer Grant, Courses Aim to Avoid Bias
The New York Times 2010 Jan 11
http://www.nytimes.com/2010/01/11/business/11drug.html
HSL17033
Brooks M
Clinical trial chiefs more likely tied to industry
Reuters 2010 Jan 11
http://www.nationalpost.com/life/health/story.html?id=164c09c6-5d8c-48e8-8d59-4fd62376ff54
HSL17054
Meier B
Lawsuit Challenges Marketing of Stents
The New York Times 2010 Jan 11
http://www.nytimes.com/2010/01/11/business/15stent.html
HSL17055
Edwards J
OxyContin Study Concealed Withdrawal Rates; 10,000 Copies Sent to Doctors
BNet 2010 Jan 11
http://industry.bnet.com/pharma/10006060/oxycontin-study-concealed-withdrawal-syndrome-rates-10000-copies-sent-to-doctors/
HSL17092
Arnold M
Pfizer $3m Stanford CME grant comes with few strings attached
Medical Marketing & Media 2010 Jan 11
http://www.mmm-online.com/pfizer-3m-stanford-cme-grant-comes-with-few-strings-attached/article/161022/
HSL17103
Heavey S
US GAO finds 'extraordinary' increases in drug prices
Reuters 2010 Jan 11
http://www.reuters.com/article/idUSN1116984120100111
HSL17064
Sismondo S
Following a Wyeth article
Sergio Sismondo 2010 Jan 9
http://post.queensu.ca/~sismondo/page1/files/47841c3a978737650d579ee350234140-4.html
HSL17019
Buczak A, Lukasik IM, Witek A.
Use of Painkillers by Polish Secondary School Students and the Influence of TV Commercials.
Gesundheitswesen 2010 Jan 8;
https://www.thieme-connect.com/DOI/DOI?10.1055/s-0029-1242788
HSL17130
Taylor L
EU opens antitrust proceedings against Lundbeck
Pharma Times 2010 Jan 8
http://www.pharmatimes.com/WorldNews/article.aspx?id=17181
HSL17690
Silverman GK, Loewenstein GF, Anderson BL, Ubel PA, Zinberg S, Schulkin J
Failure to discount for conflict of interest when evaluating medical literature: a randomised trial of physicians
J Med Ethics 2010 Jan 8; 36:(5):265-270
http://jme.bmj.com/content/36/5/265.abstract
HSL17029
Silverman E
Abbott Pays $22.5M To States Over TriCor
Pharmalot 2010 Jan 7
http://www.pharmalot.com/2010/01/abbott-pays-225m-to-states-over-tri-cor/
HSL17034
Mangan L
Before and after: an old-fashioned kind of advertising scandal
The Guardian 2010 Jan 7
http://www.guardian.co.uk/lifeandstyle/2010/jan/07/clean-and-clear-banned-ad
HSL17076
Brito A
Tribunal de Comércio confirma condenação da Concorrência às farmacêuticas
Publico 2010 Jan 7
http://economia.publico.clix.pt/noticia.aspx?id=1416680
HSL17011
Mack J
A Common Goal of Research and Marketing: Fool the Doctor
Pharma Marketing Blog 2010 Jan 6
http://pharmamkting.blogspot.com/2010/01/common-goal-of-research-and-marketing.html
HSL17030
Barnes B
Diet Drug Maker Glaxo to Pay for a Film on Eating
The New York Times 2010 Jan 6
http://www.nytimes.com/2010/01/07/business/media/07documentary.html
HSL17012
Mack J
Filling the Social Media Void: Shout or Be Shouted At!
Pharma Marketing Blog 2010 Jan 5
http://pharmamkting.blogspot.com/2010/01/filling-social-media-void-shout-or-be.html
HSL16995
Alexander J
Health Min asks MCI to take action against doctors taking freebies from pharma cos
PharmaBiz.com 2010 Jan 4
http://www.essentialdrugs.org/indiadrug/archive/201003/msg00004.php
HSL16997
Health of a nation 'The govt must not budge to any lobbying.'
Deccan Herald 2010 Jan 4
http://www.deccanherald.com/content/44736/health-nation.html
HSL16998
Taylor L
EU to probe pharma over 'false pandemic'
Pharma Times 2010 Jan 4
http://www.pharmatimes.com/WorldNews/article.aspx?id=17147
HSL17001
Poses RM
One Small Step Towards Reducing Conflicts of Interest Affecting Academic Medical Leaders
Health Care Renewal Blog 2010 Jan 4
http://hcrenewal.blogspot.com/2010/01/one-small-step-towards-reducing.html
HSL17002
Mack J
The Trouble with YouTube: YAZ Case Study
Pharma Marketing Blog 2010 Jan 4
http://pharmamkting.blogspot.com/2010/01/trouble-with-youtube-yaz-case-study.html
HSL17013
Carlat D
Should Doctors Serve on Drug Company Boards?
The Carlat Psychiatry Blog 2010 Jan 4
http://carlatpsychiatry.blogspot.com/2010/01/should-doctors-serve-on-drug-company.html
HSL16990
Goozner M
Ethics in Medicine and Journalism
GoozNews 2010 Jan 3
http://www.medcitynews.com/2010/01/ethics-in-medicine-and-journalism/
HSL17000
Kowalczyk L
MGH parent curbs fees to staff from drug makers
The Boston Globe 2010 Jan 3
http://www.boston.com/business/healthcare/articles/2010/01/03/partners_healthcare_curbs_fees_staff_can_accept_from_drug_makers/
HSL17003
Rind D
Revere's Thought Experiment and Observational Studies
Evidence in Medicine 2010 Jan 3
http://www.evidenceinmedicine.org/2010/01/reveres-thought-experiment-and-observational-studies.html
HSL16988
Martin D
James L. Goddard, Crusading F.D.A. Leader, Dies at 86
The New York Times 2010 Jan 2
http://www.nytimes.com/2010/01/02/health/02goddard.html
HSL16989
Wilson D
Harvard Teaching Hospitals Cap Outside Pay
The New York Times 2010 Jan 2
http://www.nytimes.com/2010/01/03/health/research/03hospital.html?pagewanted=print
HSL16992
Brody H
Slicing Salami as Drug Marketing
Hooked: Ethics, Medicine and Pharma 2010 Jan 2
http://brodyhooked.blogspot.com/2010/01/slicing-salami-as-drug-marketing.html
HSL16999
Jain K
Doctors question impact of code of conduct without punishment
Business Standard 2010 Jan 2
http://www.business-standard.com/india/news/doctors-question-impactcodeconduct-without-punishment/381448/
HSL17137
Drug development for neglected diseases: pharma's influence
The Lancet 2010 Jan 2; 375:(9708):2
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)62123-1/fulltext
HSL17138
't Hoen E
Pharmaceutical companies and the UNITAID patent pool
The Lancet 2010 Jan 2; 375:(9708):30
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)62189-9/fulltext
HSL17190
Rubin PH
Huddle Gets It Right, Most Docs Don't
The American Journal of Bioethics 2010 Jan 2; 10:(1):17-19
http://www.informaworld.com/smpp/content~content=a918536450~db=all
HSL16983
Waldie P, Robertson G
How vaccines became big business
The Globe and Mail 2010 Jan 1
http://www.theglobeandmail.com/report-on-business/flu-inc-the-big-vaccine-business/article1414474/
HSL16985
MCI sharpens ethics code for doctors
Deccan Herald 2010 Jan 1
http://www.deccanherald.com/content/44442/mci-sharpens-ethics-code-doctors.html
HSL16986
Kenney G
This Is Your Country on Drugs
In These Times 2010 Jan 1
http://www.inthesetimes.com/article/5316/this_is_your_country_on_drugs/
HSL17196
Huddle TS
Response to open peer commentaries on 'The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing'.
The American Journal of Bioethics 2010 Jan 1; 10:(1):W1-W3
http://www.informaworld.com/smpp/content~content=a918538858~db=all
HSL17016
Appelbaum PS.
Contact with pharmaceutical representatives: where does prudence lead?
Am J Bioeth 2010 Jan; 10:(1):11-3
http://www.informaworld.com/smpp/content~db=all?content=10.1080/15265160903441046
HSL17020
Verdoux H, Tournier M, Begaud B.
Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies.
Acta Psychiatr Scand 2010 Jan; 121:(1):4-10
http://www3.interscience.wiley.com/journal/122467001/abstract?CRETRY=1&SRETRY=0
HSL17021
Huddle TS
The Pitfalls of Deducing Ethics From Behavioral Economics: Why the Association of American Medical Colleges Is Wrong About Pharmaceutical Detailing
The American Journal of Bioethics 2010 Jan; 10:(1):1 - 8
http://www.informaworld.com/smpp/content~content=a918536695~db=all~jumptype=rss
HSL17086
Gold ER, Kaplan W, Orbinski J, Harland-Logan S, N-Marandi S.
Are patents impeding medical care and innovation?
PLoS Med 2010 Jan; 7:(1):e1000208
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795161/?tool=pubmed
HSL17131
Mahoney DF, Ladd E
More than a Prescriber: Gerontological Nurse Practitioners' Perspectives on Prescribing and Pharmaceutical Marketing
Geriatric Nursing 2010 Jan; 31:(1):17-27
[Epub ahead of print] Nov 13 2009
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WG2-4XNVT6R-2&_user=10&_coverDate=11/12/2009&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor=&view=c&_searchStrId=1186254657&_rerunOrigin=google&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=41a35fa4a08a3eec6404ea731bbfd78c
HSL17142
Heimans L, van Hylckama Vlieg A, Dekker FW.
Are claims of advertisements in medical journals supported by RCTs?
Neth J Med 2010 Jan; 68:(1):46-9
http://www.zuidencomm.nl/njm/getarticle.php?v=68&i=1&p=46
HSL17207
Frosch DL, Grande D, Tarn DM, Kravitz RL.
A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.
Am J Public Health 2010 Jan; 100:(1):24-32
http://ajph.aphapublications.org/cgi/content/full/100/1/24?view=long&pmid=19910354
HSL17244
Lo B
Commentary: Conflict of Interest Policies: An Opportunity for the Medical Profession to Take the Lead
Academic Medicine 2010 Jan; 85:(1):9-11
http://journals.lww.com/academicmedicine/Fulltext/2010/01000/Commentary__Conflict_of_Interest_Policies__An.9.aspx
HSL17245
Dubovsky SL, Kaye DL, Pristach CA, DelRegno P, Pessar L, Stiles K
Can Academic Departments Maintain Industry Relationships While Promoting Physician Professionalism?
Academic Medicine 2010 Jan; 85:(1):68-73
http://journals.lww.com/academicmedicine/Fulltext/2010/01000/Can_Academic_Departments_Maintain_Industry.24.aspx
HSL17246
Steinman MA, Boscardin CK, Aguayo L, Baron RB
Commercial Influence and Learner-Perceived Bias in Continuing Medical Education
Academic Medicine 2010 Jan; 85:(1):74-79
http://journals.lww.com/academicmedicine/Abstract/2010/01000/Commercial_Influence_and_Learner_Perceived_Bias_in.25.aspx
HSL17247
Kawczak S, Carey W, Lopez R, Jackman D
The Effect of Industry Support on Participants' Perceptions of Bias in Continuing Medical Education
Academic Medicine 2010 Jan; 85:(1):80-84
http://journals.lww.com/academicmedicine/Abstract/2010/01000/The_Effect_of_Industry_Support_on_Participants_.26.aspx
HSL17248
Camilleri M, Parke DW 2d
Perspective: Conflict of Interest and Professional Organizations: Considerations and Recommendations
Academic Medicine 2010 Jan; 85:(1):85-91
http://journals.lww.com/academicmedicine/Abstract/2010/01000/Perspective__Conflict_of_Interest_and_Professional.27.aspx
HSL17274
Troesken W & NBER
The Elasticity of Demand With Respect to Product Failures; or Why the Market for Quack Medicines Flourished for More Than 150 Years
The National Bureau of Economic Research 2010 Jan
http://www.nber.org/papers/w15699
HSL17623
Delorme DE, Huh J, Reid LN.
Evaluation, use, and usefulness of prescription drug information sources among Anglo and Hispanic Americans.
J Health Commun 2010 Jan; 15:(1):18-38
http://www.informaworld.com/smpp/content~db=all?content=10.1080/10810730903460526
HSL17760
Bonnemain B.
[Medical journals supported by pharmaceutical industry: a more than one century history].
Rev Hist Pharm (Paris). 2010 Jan; 57:(364):399-416
http://www.ncbi.nlm.nih.gov/pubmed/20481381
HSL17761
Evans C.
CJEM and pharmaceutical advertisements.
CJEM 2010 Jan; 12:(1):5
http://www.cjem-online.ca/v12/n1/p5
HSL18486
Grande D
Limiting the influence of pharmaceutical industry gifts on physicians: self-regulation or government intervention?
J Gen Intern Med 2010 Jan; 25:(1):79-83
http://www.ncbi.nlm.nih.gov/pubmed/19756874
HSL19184
McHenry L
Of sophists and spin-doctors: industry-sponsored ghostwriting and the crisis of academic medicine
Mens Sana Monogr 2010 Jan; 8:(1):129-45
http://www.msmonographs.org/article.asp?issn=0973-1229;year=2010;volume=8;issue=1;spage=129;epage=145;aulast=McHenry
HSL19008
Rodwin MA
Drug Advertising, CME and Physician Prescribing--A Historical Review and Reform Proposal
Conundrums and Controversies in Mental Health and Illness 2010;
HSL19022
Woloshin S, Schwartz LM.
The benefits and harms of mammography screening: understanding the trade-offs.
JAMA 2010 13; 303:(2):164-5
http://jama.ama-assn.org/content/303/2/164.long
HSL19021
Siegel CA, Schwartz LM, Woloshin S, Cole EB, Rubin DT, Vay T, Baars J, Sands BE
When should ulcerative colitis patients undergo colectomy for dysplasia? Watch between patient preferences and physician recommendations.
Inflamm Bowel Dis 2010; 16:(10):1658-62
http://onlinelibrary.wiley.com/doi/10.1002/ibd.21233/abstract;jsessionid=C7128402E28BCFA4131A1CE1622A0C01.d03t02
HSL16991
Spielmans GI, Biehn TL, Sawrey DL
A Case Study of Salami Slicing: Pooled Analyses of Duloxetine for Depression
Psychother Psychosom 2010; 79:(2):97-106
[Epub ahead of print]
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstract&ArtikelNr=270917&Ausgabe=253773&ProduktNr=223864
HSL17234
Othman N, Vitry AI, Roughead EE
Medicines information in medical journal advertising in Australia, Malaysia and the United States: A comparative cross-sectional study
Southern Med Review 2010; 3:(1):
http://www.fmhs.auckland.ac.nz/sop/smr/_docs/SMR_Vol3_ Issue1.pdf
HSL17255
Sales Through Retail Pharmacies (Twelve months to November 2009*)
2010
http://view.respond.imshealth.com/?j=fe6215717c61057a7014&m=fef31377726304&ls=fdfa17757666017475127374&l=fe9615727662037
HSL17287
Loertscher LL, Halvorsen AJ, Beasley BW, Holmboe ES, Kolars JC, McDonald FS
Pharmaceutical Industry Support and Residency Education: A Survey of Internal Medicine Program Directors
Arch Intern Med 2010; 170:(4):356-362
http://archinte.ama-assn.org/cgi/content/short/170/4/356?home
HSL17302
DTC at the Crossroads: A 'Direct' Hit or Miss?
ims 2010
http://www.imshealth.com/vgn/images/portal/cit_40000873/15/35/58020533DTCBrochure092204.pdf
HSL17315
Gough IR, Dickinson I, Maddern G, Grigg M, Hillis DJ
Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry
MJA 2010; 192:(5):293-295
http://www.mja.com.au/public/issues/192_05_010310/letters_010310_fm-3.html
HSL17316
Pratt IS, Hughes CL, Slevin TJ
Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry
MJA 2010; 192:(5):293-295
http://www.mja.com.au/public/issues/192_05_010310/letters_010310_fm-3.html
HSL17317
Barnes RK.
Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry
MJA 2010; 192:(5):293-295
http://www.mja.com.au/public/issues/192_05_010310/letters_010310_fm-3.html
HSL17494
Vitry A
Reporting of Studies on New Medicines in Major Medical Journals: A Case Study in Breast Cancer
Clinical Pharmacology & Therapeutics 2010; 87:(4):398–400
http://www.nature.com/clpt/journal/v87/n4/abs/clpt2009278a.html
HSL17537
Misra S, Ganzini L, Keepers G.
Psychiatric resident and faculty views on and interactions with the pharmaceutical industry.
Acad Psychiatry 2010 Spr; 34:(2):102-8
http://ap.psychiatryonline.org/cgi/content/full/34/2/102
HSL17591
Davis JJ
The effect of placement and modality on the recall of information from pharmaceutical web sites
Journal of Medical Marketing 2010; 10:(2):99–114
[Epub ahead of print]
http://www.palgrave-journals.com/jmm/journal/v10/n2/abs/jmm200942a.html
HSL17592
Seong Park J, Grow JM
Symptom information in direct-to-consumer antidepressant advertising and college students’ perception of the lifetime risk of depression
Journal of Medical Marketing 2010; 10:(2):123–133
[Epub ahead of print]
http://www.palgrave-journals.com/jmm/journal/v10/n2/abs/jmm200944a.html
HSL17602
Pettijohn CE, Rozell, EJ, Newman A
The relationship between emotional intelligence and customer orientation for pharmaceutical salespeople: A UK perspective
International Journal of Pharmaceutical and Healthcare Marketing 2010; 4:(1):21 - 39
http://www.emeraldinsight.com/Insight/viewContentItem.do?contentType=Article&contentId=1852702
HSL17695
Saddichha S
Disease Mongering in Psychiatry: Is It Fact or Fiction?
World Medical & Health Policy 2010; 2:(1):15
http://www.psocommons.org/wmhp/vol2/iss1/art15
HSL17708
Klemperer D
Drug Research: Marketing Before Evidence, Sales Before Safety
Dtsch Arztebl Int 2010; 107:(16):277-8
http://www.aerzteblatt.de/int/article.asp?src=heft&id=74341
HSL17709
Schott G, Pachl H, Limbach U, Gundert-Remy U, Ludwig W, Lieb K
The Financing of Drug Trials by Pharmaceutical Companies and Its Consequences: Part 1. A Qualitative, Systematic Review of the Literature on Possible Influences on the Findings, Protocols, and Quality of Drug Trials
Dtsch Arztebl Int 2010; 107:(16):279-85
http://www.aerzteblatt.de/int/article.asp?id=74342
HSL17747
Shankar PR.
Doctors and pharmaceutical promotion.
Pharos Alpha Omega Alpha Honor Med Soc 2010 Spr; 73:(2):49
http://www.ncbi.nlm.nih.gov/pubmed/20455380
HSL17748
Orentlicher D.
Prescription data mining and the protection of patients' interests.
J Law Med Ethics 2010 Mar; 38:(1):74-84.
http://www3.interscience.wiley.com/journal/123334064/abstract?CRETRY=1&SRETRY=0
HSL17755
Ackerly DC, Glickman SW, Schulman KA.
Economic content in medical journal advertisements for medical devices and prescription drugs.
Pharmacoeconomics 2010; 28:(5):429-38
http://adisonline.com/pharmacoeconomics/pages/articleviewer.aspx?year=2010&issue=28050&article=00007&type=abstract
HSL17758
Gostanian A
How the FDA can overturn Wyeth v. Levine
Am J Law Med. 2010; 36:(1):248-68.
http://www.ncbi.nlm.nih.gov/pubmed/20481407
HSL17759
Liang BA, Mackey T.
Confronting conflict: addressing institutional conflicts of interest in academic medical centers.
Am J Law Med 2010; 36:(1):136-87
http://www.ncbi.nlm.nih.gov/pubmed/20481404
HSL17839
Braillon A
Whistleblowing: Neither reward, nor protection
Journal of Public Health Policy 2010; 31:278–279
HSL17927
Clarke PM, Fitzgerald EM
Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia
eMJA 2010; 192:(11):633-636
http://www.mja.com.au/public/issues/192_11_070610/cla11057_fm.html
HSL17977
McGauran N, Wieseler B, Kreis J, Schüler Y-B, Kölsch H, Kaiser T
Reporting bias in medical research - a narrative review
Trials 2010; 11:(1):37
http://www.trialsjournal.com/content/pdf/1745-6215-11-37.pdf
HSL18246
Thomadsen BR, Heaton HT 2nd, Jani SK, Masten JP, Napolitano ME, Ouhib Z, Reft CS, Rivard MJ, Robin TT, Subramanian M, Suleiman OH
Off-label use of medical products in radiation therapy: summary of the report of AAPM Task Group No.121
Med Phys 2010; 37:(5):2300-11
http://www.ncbi.nlm.nih.gov/pubmed/20527564
HSL18338
Applbaum K
Shadow science: Zyprexa, Eli Lilly and the globalization of pharmaceutical damage control
BioSocieties 2010; 5:236-255
http://www.palgrave-journals.com/biosoc/journal/v5/n2/abs/biosoc20105a.html
HSL18386
Bucher HC.
[Benefit and pitfalls in the use of data from surrogate endpoint trials for clinical decision making].
Z Evid Fortbild Qual Gesundhwes 2010; 104:(3):230-7;
http://www.ncbi.nlm.nih.gov/pubmed/20608252
HSL18591
Haug JB, Raastad R, Berild D
[Look to Norway - but for how long?]
Tidsskriftet for Den Norske Legeforening 2010;
http://www.tidsskriftet.no/index.php?seks_id=1999673
HSL18661
Kesselheim AS, Outterson K
Fighting Antibiotic Resistance: Marrying New Financial Incentives To Meeting Public Health Goals
Health Affairs 2010; 29:(9):1689
http://content.healthaffairs.org/cgi/content/abstract/29/9/1689
HSL18668
Jost TS.
Oversight of marketing relationships between physicians and the drug and device industry: a comparative study.
Am J Law Med 2010; 36:(2-3):326-42
http://www.ncbi.nlm.nih.gov/pubmed/20726399
HSL18692
Moynihan R, Mintzes B
Sex, Lies, And Pharmaceuticals: How Drug Companies Plan To Profit From Female Sexual Dysfunction Canada: D&M Publishers Incorporate 2010
http://www.borders.com.au/book/sex-lies-and-pharmaceuticals-how-drug-companies-plan-to-profit-from-female-sexual-dysfunction/8987535/
HSL18723
Fugh-Berman AJ, Scialli AR, Bell AM
Why lunch matters: Assessing physicians' perceptions about industry relationships
Journal of Continuing Education in the Health Professions 2010; 30:(3):197-204
http://www.jcehp.com/vol30/3003_berman.asp
Page 16 of 17 pages ‹ First < 14 15 16 17 >
